These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 15131459
1. Consensus: varicella vaccination of healthy children--a challenge for Europe. Rentier B, Gershon AA, European Working Group on Varicella. Pediatr Infect Dis J; 2004 May; 23(5):379-89. PubMed ID: 15131459 [Abstract] [Full Text] [Related]
4. Varicella vaccination in Japan: necessity of implementing a routine vaccination program. Ozaki T. J Infect Chemother; 2013 Apr; 19(2):188-95. PubMed ID: 23483311 [Abstract] [Full Text] [Related]
5. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model. Wolff E, Widgren K, Scalia Tomba G, Roth A, Lep T, Andersson S. PLoS One; 2021 Apr; 16(5):e0251644. PubMed ID: 33984060 [Abstract] [Full Text] [Related]
6. [Immunization against varicella and zoster]. Floret D. Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164 [Abstract] [Full Text] [Related]
7. Perspective on live varicella vaccine. Gershon AA, Katz SL. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S242-5. PubMed ID: 18419404 [Abstract] [Full Text] [Related]
8. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs. Gabutti G, Franchi M, Maniscalco L, Stefanati A. Minerva Pediatr; 2016 Jun 01; 68(3):213-25. PubMed ID: 27125440 [Abstract] [Full Text] [Related]
9. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain. Gil-Prieto R, Garcia-Garcia L, San-Martin M, Gil-de-Miguel A. Vaccine; 2014 Dec 12; 32(52):7043-6. PubMed ID: 25444825 [Abstract] [Full Text] [Related]
10. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P. Vaccine; 2018 Feb 14; 36(8):1116-1125. PubMed ID: 29366704 [Abstract] [Full Text] [Related]
11. Live attenuated varicella vaccine. Arvin AM, Gershon AA. Annu Rev Microbiol; 1996 Feb 14; 50():59-100. PubMed ID: 8905076 [Abstract] [Full Text] [Related]
12. The safety profile of varicella vaccine: a 10-year review. Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S165-9. PubMed ID: 18419392 [Abstract] [Full Text] [Related]
13. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence. Harpaz R, van Hoek AJ. J Infect Dis; 2018 Sep 22; 218(suppl_2):S57-S62. PubMed ID: 30247602 [Abstract] [Full Text] [Related]
14. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ. Vaccine; 2012 Feb 01; 30(6):1225-34. PubMed ID: 22119592 [Abstract] [Full Text] [Related]
15. [Varicella vaccination]. Senterre J. Rev Med Brux; 2004 Sep 01; 25(4):A223-6. PubMed ID: 15516045 [Abstract] [Full Text] [Related]
16. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination. Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT. Hum Vaccin Immunother; 2016 Jul 02; 12(7):1766-76. PubMed ID: 26835890 [Abstract] [Full Text] [Related]
17. Development of varicella vaccine in Japan and future prospects. Ozaki T, Asano Y. Vaccine; 2016 Jun 17; 34(29):3427-33. PubMed ID: 27160039 [Abstract] [Full Text] [Related]
18. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil. Scotta MC, Paternina-de la Ossa R, Lumertz MS, Jones MH, Mattiello R, Pinto LA. Vaccine; 2018 Jan 04; 36(2):280-284. PubMed ID: 29198917 [Abstract] [Full Text] [Related]